Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2018, Vol. 12 Issue (1) : 84-91    https://doi.org/10.1007/s11684-017-0612-x
RESEARCH ARTICLE
Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey
N.V. Vasilyeva1,2,3(), E.R. Raush1, M.V. Rudneva2, T.S. Bogomolova1,2, A.E. Taraskina2, Yong Fang3, Fengmin Zhang3, N.N. Klimko4
1. Department of Medical Microbiology, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg 194291, Russia
2. Kashkin Research Institute of Medical Mycology, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg 194291, Russia
3. Sino-Russia Institute of Infection and Immunity, Department of Microbiology, Harbin Medical University, Harbin 150086, China
4. Department of Clinical Mycology, Allergy and Immunology, North-Western State Medical University named after I.I. Mechnikov, St. Petersburg 194291, Russia
 Download: PDF(338 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

A multicenter prospective epidemiological survey on the etiologic agents of invasive candidosis was conducted in Russia in the period of 2012–2014. Samples were collected from 284 patients with invasive candidosis and Candida species isolated by culture. The species were identified by DNA sequencing and MALDI-TOF mass-spectrometry. A total of 322 isolates were recovered, in which 96% of Сandida species belonged to six major species, namely, C. albicans (43.2%), C. parapsilosis (20.2%), C. glabrata (11.5%), C. tropicalis (9.6%), C. krusei (6.2%), and C. guilliermondii (5.3%). Most Candida species were isolated from blood samples (83.23%). Notably, the prevalence rate of C. albicans reduced from 52.38% to 32.79% (2012 vs. 2014) (P=0.01) whereas that of non-C. albicans increased from 47.62% (2012) to 67.21% (2014) (P<0.01). Species distribution differed among geographical regions; specifically, the prevalence rate of C. albicans as an etiologic agent of invasive candidosis in Siberian Federal region was significantly higher than that in other Federal regions. Results indicated a shift from C. albicans to non-C. albicans. Therefore, a detailed investigation on the contributing factors and appropriate treatment of invasive candidosis is needed.

Keywords prevalence      Сandida species      invasive candidosis      nosocomial      etiology      MALDI-TOF mass-spectrometry      candidemia     
Corresponding Author(s): N.V. Vasilyeva   
Just Accepted Date: 12 December 2017   Online First Date: 15 January 2018    Issue Date: 06 February 2018
 Cite this article:   
N.V. Vasilyeva,E.R. Raush,M.V. Rudneva, et al. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey[J]. Front. Med., 2018, 12(1): 84-91.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-017-0612-x
https://academic.hep.com.cn/fmd/EN/Y2018/V12/I1/84
Fig.1  Mass-spectrum profiles of six main Candida species: (A) C. albicans, (B) C. guilliermondii, (C) C. krusei, (D) C. tropicalis, (E) C. parapsilosis, and (F) C. glabrata.
Fig.2  Isolation rate of Candida species in Russia.
Fig.3  Isolation rate of Candida species from different samples.
Fig.4  Prevalence rate of six main Candida species from 2012 to 2014.
Fig.5  Etiology of invasive candidosis in different Federal regions of Russia (n=322).
1 Barchiesi F, Orsetti  E, Gesuita R,  Skrami E,  Manso E; Candidemia Study Group. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection 2016; 44(2): 205–213
https://doi.org/10.1007/s15010-015-0845-z pmid: 26410297
2 Cornely OA, Bassetti  M, Calandra T,  Garbino J,  Kullberg BJ,  Lortholary O,  Meersseman W,  Akova M,  Arendrup MC,  Arikan-Akdagli S,  Bille J,  Castagnola E,  Cuenca-Estrella M,  Donnelly JP,  Groll AH,  Herbrecht R,  Hope WW,  Jensen HE,  Lass-Flörl C,  Petrikkos G,  Richardson MD,  Roilides E,  Verweij PE,  Viscoli C,  Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18(Suppl 7): 19–37
https://doi.org/10.1111/1469-0691.12039 pmid: 23137135
3 Lionakis MS, Netea  MG. Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog 2013; 9(1): e1003079
https://doi.org/10.1371/journal.ppat.1003079 pmid: 23300452
4 Zaoutis TE, Argon  J, Chu J,  Berlin JA,  Walsh TJ,  Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005; 41(9): 1232–1239
https://doi.org/10.1086/496922 pmid: 16206095
5 Tortorano AM, Kibbler  C, Peman J,  Bernhardt H,  Klingspor L,  Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27(5): 359–366
https://doi.org/10.1016/j.ijantimicag.2006.01.002 pmid: 16647248
6 Hassan I, Powell  G, Sidhu M,  Hart WM,  Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Infect 2009; 59(5): 360–365
https://doi.org/10.1016/j.jinf.2009.08.020 pmid: 19744519
7 Bongomin F, Gago  S, Oladele R,  Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. J. Fungi 2017; 3(4): 57–86
https://doi.org/10.3390/jof3040057
8 Klimko N, Kozlova  Y, Khostelidi S,  Shadrivova O,  Borzova Y,  Burygina E,  Vasilieva N,  Denning DW. The burden of serious fungal diseases in Russia. Mycoses 2015; 58(Suppl 5): 58–62
https://doi.org/10.1111/myc.12388 pmid: 26449508
9 Pfaller MA, Pappas  PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43(Supplement 1): S3–S14
https://doi.org/10.1086/504490
10 Pemán J, Cantón  E, Quindós G,  Eraso E,  Alcoba J,  Guinea J,  Merino P,  Ruiz-Pérez-de-Pipaon MT,  Pérez-del-Molino L,  Linares-Sicilia MJ,  Marco F,  García J,  Roselló EM,  Gómez-G-de-la-Pedrosa E,  Borrell N,  Porras A,  Yagüe G; FUNGEMYCA Study Group. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67(5): 1181–1187
https://doi.org/10.1093/jac/dks019 pmid: 22351683
11 Pfaller MA, Diekema  DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20(1): 133–163
https://doi.org/10.1128/CMR.00029-06 pmid: 17223626
12 Tan BH, Chakrabarti  A, Li RY,  Patel AK,  Watcharananan SP,  Liu Z, Chindamporn  A, Tan AL,  Sun PL, Wu  UI, Chen YC; Asia Fungal Working Group (AFWG). Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 2015; 21(10): 946–953
https://doi.org/10.1016/j.cmi.2015.06.010 pmid: 26100373
13 Pfaller M, Neofytos  D, Diekema D,  Azie N, Meier-Kriesche  HU, Quan SP,  Horn D. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis 2012; 74(4): 323–331
https://doi.org/10.1016/j.diagmicrobio.2012.10.003 pmid: 23102556
14 Montagna MT, Caggiano  G, Lovero G,  De Giglio O,  Coretti C,  Cuna T, Iatta  R, Giglio M,  Dalfino L,  Bruno F,  Puntillo F. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection 2013; 41(3): 645–653
https://doi.org/10.1007/s15010-013-0432-0 pmid: 23463186
15 Cuenca-Estrella M, Verweij  PE, Arendrup MC,  Arikan-Akdagli S,  Bille J,  Donnelly JP,  Jensen HE,  Lass-Flörl C,  Richardson MD,  Akova M,  Bassetti M,  Calandra T,  Castagnola E,  Cornely OA,  Garbino J,  Groll AH,  Herbrecht R,  Hope WW,  Kullberg BJ,  Lortholary O,  Meersseman W,  Petrikkos G,  Roilides E,  Viscoli C,  Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18(Suppl 7): 9–18
https://doi.org/10.1111/1469-0691.12038 pmid: 23137134
16 Clinical and Laboratory Standards Institute (CLSI). Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. CLSI document MM18-A. Wayne, Pennsylvania, 2008
17 Biotyper MALDI. 3.1. User manual revision 1. Bruker Daltonics, Bremen: 2012
18 Bassetti M, Peghin  M, Carnelutti A,  Righi E,  Merelli M,  Ansaldi F,  Trucchi C,  Alicino C,  Sartor A,  Toniutto P,  Wauters J,  Laleman W,  Tascini C,  Menichetti F,  Luzzati R,  Brugnaro P,  Mesini A,  Raviolo S,  De Rosa FG,  Lagunes L,  Rello J,  Dimopoulos G,  Colombo AL,  Nucci M,  Vena A, Bouza  E, Muñoz P,  Tumbarello M,  Losito R,  Martin-Loeches I,  Viscoli C. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med 2017; 43(4): 509–518
https://doi.org/10.1007/s00134-017-4717-0 pmid: 28271321
19 Trouvé C, Blot  S, Hayette MP,  Jonckheere S,  Patteet S,  Rodriguez-Villalobos H,  Symoens F,  Van Wijngaerden E,  Lagrou K. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis 2017; 36(4): 649–655
https://doi.org/10.1007/s10096-016-2841-3 pmid: 27858242
20 Sasso M, Roger  C, Sasso M,  Poujol H,  Barbar S,  Lefrant JY,  Lachaud L. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: 10-year study. Mycoses2017 Jul 31 [Epub ahead of print]
https://doi.org/10.1111/myc.12661 pmid: 28758337
21 Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 2014; 31(1): 42–48
https://doi.org/10.1016/j.riam.2013.10.001 pmid: 24270071
22 Eggimann P, Bille  J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 2011; 1(1): 37
https://doi.org/10.1186/2110-5820-1-37 pmid: 21906271
23 Yang CW, Barkham  TM, Chan FY,  Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003; 41(1): 472–474
https://doi.org/10.1128/JCM.41.1.472-474.2003 pmid: 12517898
24 Puig-Asensio M, Padilla  B, Garnacho-Montero J,  Zaragoza O,  Aguado JM,  Zaragoza R,  Montejo M,  Muñoz P,  Ruiz-Camps I,  Cuenca-Estrella M,  Almirante B; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 2014; 20(4): O245–O254
https://doi.org/10.1111/1469-0691.12380 pmid: 24125548
25 Fu J, Ding  Y, Wei B,  Wang L, Xu  S, Qin P,  Wei L, Jiang  L. Epidemiology of Candida albicans and non-C. albicans of neonatal candidemia at a tertiary care hospital in western China. BMC Infect Dis 2017; 17(1): 329
https://doi.org/10.1186/s12879-017-2423-8 pmid: 28477628
26 Pfaller MA, Diekema  DJ, Rinaldi MG,  Barnes R,  Hu B, Veselov  AV, Tiraboschi N,  Nagy E, Gibbs  DL. Results from the AR-TEMIS DISK global antifungal surveillance study: a 6.5-year analysis of the worldwide susceptibility of yeasts to fluconazole and voricon-azole using standardized disk diffusion testing. J Clin Microbiol 2005; 43(12): 5848–5859
https://doi.org/10.1128/JCM.43.12.5848-5859.2005 pmid: 16333066
27 Pfaller MA, Jones  RN, Castanheira M. Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006–2011. Mycoses 2014; 57(10): 602–611
https://doi.org/10.1111/myc.12206 pmid: 24863164
[1] Xinjian Li,Minna Cheng,Hao Zhang,Ting Ke,Yisheng Chen. Prevalence and determinations of physical inactivity among public hospital employees in Shanghai, China: a cross-sectional study[J]. Front. Med., 2015, 9(1): 100-107.
[2] Hussein Naji, Rajaa Mustafa. Circumcision of preschool boys in Baghdad, Iraq: prevalence, current practice and complications[J]. Front Med, 2013, 7(1): 122-125.
[3] Xinjian Li, Jiying Xu, Haihong Yao, Yanfei Guo, Minna Chen, Wei Lu. Obesity and overweight prevalence and its association with undiagnosed hypertension in Shanghai population, China: a cross-sectional population-based survey[J]. Front Med, 2012, 6(3): 322-328.
[4] Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD, . Prevalence of cardiovascular diseases in China[J]. Front. Med., 2010, 4(1): 16-20.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed